Related Experiment Videos
The minimum protective level of antibodies in smallpox
Bulletin of the World Health Organization
|January 1, 1975
Summary
Vaccination protects against smallpox, even with low antibody levels. Unvaccinated individuals with low neutralizing antibodies faced a higher risk, but not all developed the disease.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- Smallpox, a eradicated viral disease, remains a public health concern.
- Understanding immune responses, particularly antibody levels, is crucial for assessing protection.
- Previous studies highlight the importance of vaccination in preventing smallpox.
Purpose of the Study:
- To investigate the relationship between antibody levels and smallpox infection in contacts of cases.
- To evaluate the protective effect of vaccination against smallpox disease.
Main Methods:
- Blood samples were collected from 57 contacts of 6 confirmed smallpox cases.
- Samples were tested for haemagglutination-inhibiting (HI) and neutralizing antibodies.
- Infection status and vaccination history were recorded for all contacts.
Main Results:
- All 6 unvaccinated contacts who developed smallpox had low neutralizing antibody titres (≤10).
- 6 unvaccinated contacts with similar low antibody levels did not contract smallpox.
- None of the 41 vaccinated contacts developed smallpox, irrespective of their antibody levels.
Conclusions:
- Smallpox vaccination appears to provide robust protection against disease, even with low antibody titres.
- Low neutralizing antibody levels in unvaccinated individuals may indicate increased susceptibility but not certainty of infection.
- Further research into correlates of protection is warranted.